Purpose: To investigate and report the reliability of detection and grading of diabetic retinopathy by direct ophthalmoscopy through a dilated pupil by general physicians (non-ophthalmologists) and optometrists who have undergone a short period of training. Methods: A total of 400 eyes of 200 diabetes patients were examined by two non-ophthalmologists. Their observations were compared with an ophthalmologist's diagnoses for the same patients. Results: The diagnoses made by the general physician (kappa = 0.8381, SE = 0.041) and the optometrist (kappa = 0.7186, SE = 0.051) showed good rates of agreement with the ophthalmologist's diagnoses. Conclusions: The provision of appropriate screening protocols and follow-up parameters can enable primary care physicians and support personnel to reliably screen individuals for retinopathy in diabetes. This will reduce the workload of tertiary hospitals, and provide optimal services to the huge majority of the Indian population that has limited access to eye care services.
Introduction
Diabetic retinopathy is the most serious complication of diabetes involving the eye. Almost all diabetes mellitus patients will experience some degree of diabetic retinopathy over time, the prevalence of which increases with duration of diabetes (Klein & Klein 1995) . Data from the Diabetic Retinopathy Study and other sources suggest that about 50% of untreated patients with proliferative diabetic retinopathy become legally blind within 5 years (Diabetic Retinopathy Study Research Group 1981) . However, only 5% of treated patients with proliferative diabetic retinopathy become legally blind within the same period, according to the Early Treatment Diabetic Retinopathy Study (Ferris 1993) . Early diagnosis and treatment of diabetic retinopathy in Sweden has resulted in referrals to low vision clinics falling by one-third over 5 years (Backlund et al. 1997) . In Iceland, where 90% of patients with type 1 diabetes are registered and recalled for regular examinations, dramatic results in the prevention of visual impairment have been achieved (Kristinsson et al. 1997 ).
The world diabetic population is expected to double by 2010, reaching an estimated 221 million (Amos et al. 1997) . It is not inaccurate to state that the underlying cause of blindness in the majority of diabetes patients is not diabetic retinopathy itself, but a missed diagnosis of diabetic retinopathy. Screening should be undertaken to detect disease of any severity, as the existence of any retinopathy has significant management implications (Wood et al. 1998) . A study in New Zealand found that hospital diabetologists achieved good levels of accuracy when screening diabetes patients for retinopathy with ophthalmoscopy, attaining sensitivities of 70% for any retinopathy and 80-90% for sight-threatening retinopathy (Lienert 1989) . The sensitivity of ophthalmoscopy for screening for diabetic retinopathy increases with the level of training given to the health care providers, along with their experience in performing eye examinations (Brechner et al. 1992 ). The present study reports findings on screening for diabetic retinopathy by non-ophthalmologists in India.
Methods and Materials
A recent medical graduate (MBBS: Bachelor of Medicine and Bachelor of Surgery; approved by the Medical Council of India) and a recently qualified optometrist (BSc: Bachelor of Science, Ophthalmic Techniques; certified by the All India Institute of Medical Sciences) administered a specially designed diabetic retinopathy screening protocol to 200 patients (400 eyes). Neither of the practitioners had any professional exposure to or specific interest in diabetic retinopathy prior to the present study.
The categorization of retinopathy was established by the first author (LKV), who is an ophthalmologist. He has 16 years' clinical experience in ophthalmology and 12 years' experience in medical and surgical vitreo-retinal work. His categorization defined the reference standard for the study. The diagnoses made by the general physician (GP) and the optometrist were compared to this standard.
The GP and the optometrist were given a total of 25 hours of training, spread over 5 weeks. This consisted of demonstration of colour fundus photographs and fundus evaluation of patients with findings representative of common types of diabetic retinal disease.
Diabetic retinopathy was categorized as being 'absent', 'non sight-threatening diabetic retinopathy' or 'sight-threatening diabetic retinopathy'. The 'absent' label was applied when there was no evidence of any of the following: microaneurysm, haemorrhages, hard exudates, cotton wool spots, venous beading and loops. Sight-threatening diabetic retinopathy was categorized as maculopathy, severe non-proliferative diabetic retinopathy or proliferative diabetic retinopathy.
Maculopathy was defined by the presence of exudates and/or haemorrhages within one disc diameter of the centre of the macula (slit lamp biomicroscopy was not carried out in any patient for this study). Greying in the macula was taken as suggesting the presence of macular oedema or thickening.
Severe non-proliferative diabetic retinopathy was defined by the presence of any one of the following: intraretinal haemorrhages in four quadrants, venous beading in two quadrants and severe intraretinal microvascular abnormalities.
Proliferative diabetic retinopathy was characterized by neovascularization on or within one disc diameter of the optic disc (NVD), or neovascularization elsewhere on the retina (NVE), or neovascularization of the iris (NVI). Proliferative diabetic retinopathy was diagnosed in the presence of more than two of the following high risk characteristics:
(1) presence of new vessels; (2) NVD; (3) NVD equivalent to one-third of disc area in extent or NVE equivalent to half of disc area (if both NVE and NVD were present, the severity of the NVD was counted), and (4) vitreous or preretinal haemorrhage (Diabetic Retinopathy Study Research Group 1976 , 1981 .
Any diabetic retinopathy that did not conform to the above criteria of sightthreatening diabetic retinopathy was diagnosed as non sight-threatening diabetic retinopathy.
A consecutive series of 200 patients (400 eyes) with diabetes were recruited from the Medical Ophthalmology Clinic at the Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi. The study was carried out over a period of 10 months from December 2000 to September 2001. All patients gave informed verbal consent to participation in the study. All were instructed not to provide any information on the health status of their eyes to either the recent graduates or the ophthalmologist.
The eyes were dilated with 5% phenylephrine hydrochloride and 1% tropicamide eye drops prior to screening.
All examiners performed fundus evaluation by direct ophthalmoscopy (Beta 200 model, Heine 1 ), first on the right eye and then on the left eye of each patient, and recorded their respective diagnostic impressions independently on separate data collection forms for right and left eyes. The associated bias is discussed later. None of the examiners were aware of the findings recorded by the others. Information about the patients was masked from the ophthalmologist. Data on socio-demographic characteristics, duration of diabetes mellitus, status of pupillary dilation and ocular media clarity were noted by the ophthalmologist on a separate proforma, after the GP and the optometrist had each completed their proformas. Data were analysed by an independent investigator after the entire screening programme was completed.
Analysis
The data was analysed using SPSS (Statistical Package for Social Sciences) (Release 10.0.1, 27.10.99, # SPSS Inc.). The agreement rate was defined as the proportion of instances in which the diagnosis made by either the GP or the optometrist matched the diagnosis made by the ophthalmologist. Kappa values were calculated for right and left eyes separately.
It was considered that the presence of sight-threatening diabetic retinopathy in either eye of a patient merited referral to an ophthalmologist; therefore, 'patient-diagnosis' was also analysed independently. This meant that if either eye of a patient was diagnosed as having sight-threatening diabetic retinopathy, the patient-diagnosis was taken to be sight-threatening diabetic retinopathy.
Results
A total of 125 male and 75 female subjects were enrolled in the study. Their ages ranged from 20 to 81 years. The mean age of the subjects was 53.1 years (male ¼ 52.9 years, female ¼ 53.4 years), with 68.8% of males and 70.7% of females aged 50 years or older. Only eight of 200 patients (4%, aged 30 years or under at onset of diabetes) had type 1 diabetes. The remaining 96% (aged over 30 years at onset of diabetes) had type 2 diabetes mellitus. The duration of diabetes mellitus ranged from 1.5 months to 39 years. In 50.5% of subjects, disease duration was less than 10 years. The mean duration was 10.9 years. The pupil could not be dilated fully (6 mm or more) in 15 (3.75%) of 400 eyes. Ocular media was clear (visibility of grade 2 vessels or better, as graded by the ophthalmologist) in 331 (82.75%) of 400 eyes. Diabetic retinopathy was present in 258 (64.5%) eyes and was classified by the ophthalmologist as being non sight-threatening diabetic retinopathy in 92 eyes (23%) and sight-threatening diabetic retinopathy in 166 eyes (41.5%).
Diagnoses of diabetic retinopathy made by the GP and the optometrist were compared separately for each eye with those made by the ophthalmologist (Table 1 and Table 3 Comparisons of grading of severity of diabetic retinopathy among the groups were also determined (Table 1  and Table 4 The clarity of the ocular media affected the diagnoses made by the GP and the optometrist, compared with those made as a reference standard by the ophthalmologist. A total of 69 eyes did not have clear ocular media (as rated by the ophthalmologist) due to a variety of reasons such as vitreous haemorrhage, cataract, etc. The diagnosis of diabetic retinopathy was missed (labelled as no retinopathy) in 2.9% (2/69) of cases, under-diagnosed (labelled as non sight-threatening rather than sight-threatening diabetic retinopathy) in 2.9% (2/69) of cases and overdiagnosed (labelled as sight-threatening rather than non sight-threatening diabetic retinopathy) in 8.7% (6/69) of cases by the GP. The diagnosis of diabetic retinopathy was missed in 14.5% (10/69) of cases, under-diagnosed in 5.8% (4/69) of cases and over- Pupil size did not have any effect on detection of diabetic retinopathy for the GP; all the diagnoses made by the GP exactly matched those made by the ophthalmologist in the 15 eyes with pupil diameter of less than 6 mm. In eyes with a pupil diameter of less than 6 mm, the optometrist missed the diagnosis of retinopathy in 13.3% (2/15) of cases. He correctly diagnosed the type of diabetic retinopathy where it was present in the remaining 13 eyes with pupil diameter of less than 6 mm.
Discussion
Data from two previous clinical trials showed that treatment for diabetic retinopathy may be up to 90% effective in eradicating severe loss of vision (<5/200) with present treatment strategies (Ferris 1993) . Screening for diabetic retinopathy should be mandatory for all diabetes patients as diabetes mellitus is now assuming alarming epidemic proportions in developing countries.
However, this represents merely the tip of the iceberg. Patients with visionthreatening diabetic retinopathy may not have symptoms. As a result, ongoing evaluation for diabetic retinopathy is a valuable strategy.
Studies have shown that, when screening for diabetic retinopathy using direct ophthalmoscopy through dilated pupils, 'miss' rates for sightthreatening diabetic retinopathy are as high as 52% for high street optometrists, 45% for general practitioners and 33% for hospital physicians (Buxton et al. 1991 ). In our study, when examinations were carried out on eyes with pharmacologically dilated pupils, the GP's 'miss' rate for sight-threatening diabetic retinopathy with respect to the reference standard was only 6.63% (11/166), and only two (1.2%) cases out of a total of 166 with sight-threatening diabetic retinopathy were wrongly labelled as having no diabetic retinopathy. This can be compared to the optometrist's 'miss' rate for sightthreatening diabetic retinopathy with respect to the reference standard of 28.31% (47/166), with 21 (12.65%) cases out of 166 with sight-threatening diabetic retinopathy being wrongly labelled as having no diabetic retinopathy. The reason for this disagreement between the graders might be that the GP had undergone a longer and more intensive period of training of 5.5 years, while the optometrist had been trained for 3 years, both of which are standard training periods in India for their respective roles.
A recent study of optometrists in London, accredited after specialist training, found higher levels of accuracy (Burnett et al. 1998 ). Participants used mydriasis as a criterion for diagnosis but it is not clear which type of ophthalmoscope was used. The sensitivity of the test for referable eye disease was 100% (no cases were missed); specificity was 94% (94% of cases referred had treatable retinopathy). However, in this study the reference standard referred to diagnoses made by a general ophthalmologist rather than an ophthalmologist with experience in vitreo-retinal disease, as is the case in our study. In addition, there is no information on the clarity of the media.
Pupil size had no effect on detection of diabetic retinopathy by the GP in our study: all diagnoses made by the GP exactly matched those made by the ophthalmologist in eyes where the pupil diameter was less than 6 mm. Smaller pupillary diameter negatively affected the diagnostic acumen of the optometrist, but this was not statistically significant (kappa ¼ 0.783, SE ¼ 0.139). The diagnostic findings of both the GP and the optometrist were affected more by the clarity of the ocular media than by the size of the pupil. In cases with hazy ocular media, 85.5% (59/69, kappa ¼ 0.753, SE ¼ 0.072) of the GP's diagnoses agreed with standard reference diagnoses, as did 72.5% (50/69, kappa ¼ 0.544, SE ¼ 0.084) of the optometrist's diagnoses. The difference in agreement between the two groups was not statistically significant. However, we should not underestimate the fact that adequate mydriasis is otherwise considered a prerequisite in evaluation for diabetic retinopathy.
Direct ophthalmoscopy through a pharmacologically dilated pupil, carried out by the GP after 25 hours of training, was found to be sensitive (more than 80%) but not sufficiently specific (less than 95%) as a means of Our study demonstrated that the GP was less likely to miss a diagnosis of diabetic retinopathy, but was more likely to diagnose normal eyes as having diabetic retinopathy than was the optometrist. However, the optometrist might miss cases of sight-threatening diabetic retinopathy (28.31% of cases missed) and even grade patients as having no diabetic retinopathy (12.65%). The GP did not miss many cases of sight-threatening retinopathy (only 6.63% cases missed) in comparison to the optometrist, although this accuracy comes at the expense of diagnosing some non sight-threatening cases as sight-threatening diabetic retinopathy.
Analysis of rates of patient-diagnosis of sight-threatening diabetic retinopathy showed the GP had performed better then the optometrist, with agreement rates of 91.0% and 86.5%, respectively. This difference is statistically significant. Analysis of rates of patient-diagnosis of any grade of diabetic retinopathy similarly revealed that the GP had performed better than the optometrist, with agreement rates of 93.0% and 87.0%, respectively. This difference is not statistically significant. Although both the optometrist and the GP reported low specificity (less than 95%), both of them were independently sensitive (more than 80%) in detecting diabetic retinopathy in either eye.
Our study is the first of its kind to be carried out in the Indian subcontinent. It provides relevant data indicating that general physicians and optometrists are independently reliable in detecting diabetic retinopathy using direct ophthalmoscopy in a pharmacologically dilated pupil, and therefore, can be provided with a screening protocol which states the parameters for follow-up and referral of diabetes patients. This shows that, given adequate training, nonophthalmologists (general physicians and optometrists) can appropriately refer cases of diabetic retinopathy to secondary or tertiary level hospitals so that appropriate management can be instituted.
Now that diabetes mellitus is assuming horrifying epidemic proportions, even in developing countries such as India, screening for diabetic retinopathy has to be made mandatory for all diabetes patients. This will not be practical if only ophthalmologists are able to carry out screening. It is therefore worth training GPs and optometrists in order that patients harbouring asymptomatic diabetic retinopathy can be identified from within the vast ocean of diabetes mellitus patients, even at the cost of over-referrals. A longer package of training may improve both the sensitivity and the specificity of personnel involved in primary screening. It is also important that training is repeated at periodic intervals.
